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ABSTRACT 
Diffraction and spectroscopic methods were evaluated for quantitative analysis of binary 
powder mixtures of FII(6.403) and FIII(6.525) Piracetam. The two polymorphs of Piracetam 
could be distinguished using powder X-ray diffraction (PXRD), Raman and near-infrared 
(NIR) spectroscopy. The results demonstrated that Raman and NIR spectroscopy are most 
suitable for quantitative analysis of this polymorphic mixture.  When the spectra are treated 
with the combination of multiplicative scatter correction (MSC) and second derivative data 
pretreatments, the partial least squared (PLS) regression model gave a root mean square error 
of calibration (RMSEC) of 0.94 and 0.99 % respectively. FIII(6.525) demonstrated some 
preferred orientation in PXRD analysis, making PXRD the least preferred method of 
quantification. 
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1. Introduction 
Polymorphism is a well recognised phenomenon whereby a pure chemical compound 
may exist in two or more structural orientations, each displaying different physical 
characteristics. Pseudo-polymorph - solvates and hydrates which have a molecule of solvent 
included in the crystal structure, are also possible. As different polymorphs display individual 
physical properties, such as density, melting point and solubility, polymorph purity is vitally 
important to the manufacture of chemicals, in particular, pharmaceuticals. Production of an 
unwanted, or impure, polymorph will give a product that most likely will not satisfy the 
intended purpose, or processing characteristics, of the required polymorph. Identification and 
quantification of polymorphic forms has become a necessary requirement in the production of 
modern day pharmaceuticals
1, 2
.  
A range of analytical techniques have proven suitable for the analysis and quantification 
of polymorphic mixtures. Powder X-ray diffraction (PXRD) 
3-11
, near-infrared spectroscopy 
(NIR)
12-16
, attenuated total reflectance infrared (ATR-IR) spectroscopy 
14
,  diffuse reflectance 
infrared spectroscopy (DRIFTS) 
4, 17
, Raman spectroscopy 
7, 9, 14, 18-21
 and, more recently, 
solid state 13C CPMAS NMR spectroscopy 
22
 have been used to successfully quantify 
polymorphic mixtures with methods ranging from simple univariate correlations to more 
complicated multivariate chemometric approaches.  
Piracetam (2-oxo-1-pyrrolidine acetamide) is a polymorphic drug compound (Figure 1) with five 
reported polymorphs, of which two (FIV and FV) are obtained only under high pressure (> 0.5 GPa) 
conditions 
23
. The remaining polymorphs FI, FII and FIII, have been identified and structurally 
characterized under ambient conditions 
24, 25
. FI is highly unstable at ambient conditions and can be 
isolated only by heating FII or FIII to 400 K and then quenching to room temperature. It transforms 
back to FII in the solid state within a few hours, and, as such, is not of much practical 
relevance. FII is metastable, and FIII is the stable polymorph at  ambient conditions, as 
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determined by melting data 
25
. A quantification model for polymorphic mixtures of FII and 
FIII Piracetam is desired to investigate the solution mediated polymorphic transformation of 
FII to FIII. To our knowledge, no efforts have been made in published literature to quantify 
mixtures of FII and FIII Piracetam. Throughout the literature there is some confusion over the 
nomenclature of the different polymorphs. In this work the system used for identifying the 
polymorphs is simply the form number followed by the a lattice parameter reported for the 
particular polymorph in the Cambridge Crystallographic Data Centre (CCDC) in brackets, so 
that Form II and  Form III will subsequently be referred to as FII(6.403) and FIII(6.525) 
respectively. The reference codes for piracetam FII(6.403) and FIII(6.525) in the CCDC are 
BISMEV and BISMEV01 respectively. 
As polymorphs differ fundamentally in their crystal structure, powder X-ray diffraction 
(PXRD) has become the gold standard for polymorph analysis 
2, 26
.  Quantification using 
PXRD is based on the principle that the intensity of diffraction peak for a component in a 
mixture is related to the concentration of that component in the mixture 
27
. A number of 
different peak parameters on PXRD patterns can be used for this analysis: peak height 
intensity 
4
, a ratio of peak height intensity 
6
, and peak area 
7, 8
 
,9 
being the most common in 
univariate analysis. 
 
Pharmaceutical compounds present an issue for X-ray diffraction 
analysis in that these materials can tend to display a high degree of preferred orientation. This 
can lead to difficulty in obtaining good quality, representative, reproducible diffractograms. 
Campbell Roberts et  al. completed a comprehensive quantitative study for binary mixtures of 
mannitol polymorphs, and investigated the effect of preferred orientation on the 
quantification 
5
. For particle sizes below 125 µm, this effect was deemed negligible. 
However, grinding pharmaceutical products to achieve this small particle size is not always 
feasible, as grinding may induce some phase transformation. 
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In addition to PXRD methods, vibrational spectroscopy, such as NIR, MIR, and Raman 
spectroscopies, can be used for rapid characterisation and quantification of polymorphs of 
pharmaceutical materials. NIR is associated with the overtones and combination modes of 
fundamental molecular vibrations that occur in the NIR to IR spectral region 
28
. The coupling 
of NIR with chemometrics allows for interpretation of the resulting broad spectra and it is a 
technique widely used in pharmaceutical environments, in reaction monitoring, quality 
control and quantification of pharmaceutical materials 
29, 30
. For Raman spectroscopy the 
gross selection rule is that for a Raman active vibration to occur there must be a change in 
polarizability of the molecule during its molecular vibration
31
. As many active 
pharmaceutical ingredient (APIs) contain aromatic functional groups with symmetric 
vibrational modes, they are considered to be strong Raman scatterers. Raman spectroscopy 
requires little or no sample preparation, and allows for in-situ analysis and high chemical 
specificity. However fluorescence of samples can obscure useful spectral information, 
although this may be overcome by use of NIR excitation and/or the application of various 
data pre-processing methods. Raman Spectroscopy has been utilised successfully for the 
quantification of polymorphic mixtures, tablets, capsules and for inline analysis of fluid bed 
drying processes 
32-36
.  
The objective of this work is to develop and compare quantification models for binary 
mixtures of FII(6.403) and FIII(6.525) Piracetam using PXRD, Raman, and NIR 
spectroscopy. 
2. Materials & Methods 
2.1 Preparation of polymorphs 
Piracetam was supplied by AXO Industry Ltd, Belgium, and complies with European 
Pharmacopoeia standards (CAS Number: 7491-74-9). Methanol was reagent grade. 10 g of 
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the FIII(6.525) polymorph of piracetam was prepared by recrystallization from methanol 
1
. 
The FII(6.403) polymorph was prepared by heating 5 g of FIII(6.403) crystals to 140  ºC for 
72 hr, and storing under ambient conditions for 5 days
2
. Isolation of pure polymorphic forms 
was confirmed using PXRD, DSC, and ATR-FTIR spectroscopy (Supplementary 
Information). 
 
2.2 Preparation of polymorphic standards 
The pure forms were ground individually in an agate mortar with a pestle for 30 seconds 
each, and a 90 – 125 µm sieve fraction collected for standard preparation. The possibility of 
any phase change occurring during grinding was discounted by testing a control sample 
before and after grinding. 100 mg binary calibration mixtures containing 0, 1, 5, 10, 20, 30, 
40, 50 60, 70, 80, 90, 95, 99 and 100 % of FII(6.403), with the remaining mass balance 
provided by FIII(6.525), were prepared by gentle mixing of weighed quantities of both 
polymorphs in an agate mortar with pestle. Validation mixtures containing 15, 50, 75 and 
85% of FII(6.403) were prepared in the same way.  
2.3 X-ray powder diffractometry 
Diffraction patterns of the samples were obtained in reflectance mode using a Phillips 
PANalytical X’Pert MPD Pro instrument with a Cu Kα source (λ = 1.5418 Å), nickel filter, 
fixed divergence slit of  ½
o
, and accelerating voltage and anode current set as 40 kV and 35 
mA respectively. Data was recorded over the range 8 to 35   2θ, using a step size of 0.017 o2θ, 
a count time of 33 sec per step, a scan speed of 0.064   2θ/ sec, and a sample rotation of 4 rpm 
using PANanalytical Data Collector, version 2.0.  
The polymorph mixture was placed on a silicon crystal zero-background disc, which 
was mounted into a sample holder using a clip. The sample surface was smoothed with a 
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glass slide. The samples were measured consecutively in triplicate. Sample preparation using 
pressed cellulose discs was also attempted, but this was found to result in amplified preferred 
orientation effects in the recorded diffraction patterns.   
Reference PXRD patterns for the FII and FIII polymorph were generated with the CIF 
files BISMEV and BISMEV01 respectively, from the Cambridge Crystallographic Data 
Centre (CCDC), using Mercury 2.4. 
2.4 Raman Spectroscopy 
Raman spectra were collected at room temperature using a RamanStation spectrometer 
(AVALON Instruments Ltd., Belfast, Northern Ireland; now PerkinElmer) equipped with 785 
nm laser diode excitation, cooled (-77 ºC) CCD detector, and a motorised XYZ sample stage. 
The samples were placed in aluminium crucibles (Thorn Scientific Services Ltd, UK) of 2 
mm depth and 5 mm diameter and measured with a laser power of 79.9 mW at the sample 
(spot size ~200 µm). An exposure time of 2 s × 10 acquisitions was used for each 
measurement and spectra were collected over a range of 250 to 3310 cm
-1 
with 4 cm
-1
 
resolution. Each sample was analyzed on a 3 x 3 grid with 0.5 mm spacing to reduce sub-
sampling effects. An average spectrum was calculated from the 9 individual spectra.  
2.5 NIR spectroscopy 
NIR data were collected using a Perkin Elmer Spectrum One spectrometer fitted with an 
NIR reflectance attachment. NIR spectra were collected with interleaved scans in the 10000–
4000cm
-1
 range with a resolution of 8 cm
-1
, using 32 co-added scans. Sample vials (SUN-Sri 
Ltd.) were shaken and repositioned between triplicate measurements of each sample. 
2.6 Data analysis 
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X'Pert HighScore Plus software (PANalytical) was used to calculate peak height 
intensity and area, and correct the shifts along the 2θ axis for PXRD scans. The cubic spline 
data interpolation technique was then used to reconstruct the PXRD scans. Multivariate data 
analysis was carried out using The Unscrambler v9.8 software (Camo, Norway). To remove 
unimportant baseline (offset) interferences from samples or correct scatter effects and 
accentuate spectral signals of interest, various different pre-processing methods, including 
multiplicative scatter correction (MSC), standard normal variate (SNV), first and second 
derivative and their combinations were applied for Raman and NIR data. Savitzki-Golay first 
and second derivative calculations were performed with a window size of 15 points and a 
second order polynomial. Mean normalization was used for PXRD data. The PXRD and 
spectroscopic data were subjected to mean centring prior to partial least squares (PLS) 
analysis. The optimal number of PLS factors was determined by using a leave-one-out cross 
validation procedure. The performance of the model was evaluated by using the correlation 
coefficient (R
2
) and root mean square error (RMSE) of the calibration (RMSEC), cross-
validation (RMSECV) and prediction (RMSEP). RMSE was calculated using the following 
equation, 
n
yy
n
i ii   1
2)ˆ(
RMSE     (1) 
where iyˆ , iy and n represent the calculated value, the actual value and the number of 
samples. 
3. Results and Discussion 
3.1 Characterisation of Piracetam polymorphs  
Production of the pure FII(6.403) and FIII(6.525) polymorphs was confirmed with 
PXRD, DSC and FTIR analysis, as seen in Figure 2 and Supplementary Information. The 
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experimental PXRD patterns were compared to the theoretical patterns (Figure 2) and no 
polymorph impurity was detected. Some preferred orientation was evident in the FIII(6.525) 
pattern. Transmission mode PXRD could have provided for superior diffraction results, but 
this capability was not available in this study. The FTIR spectra and DSC thermograms 
(Supplementary Information) were compared to those published by Pavlova et al. 
24
 and 
Kuhnert-Brandstaetter et al. 
25
. The endothermic peaks in the DSC thermograms indicted that 
the transformation to FI(6.747) at 114 and 120 ºC in FII(6.403) and FIII(6.525) respectively 
and melting of FI(6.747) at 152 ºC.  
3.2 Powder X-Ray Diffraction Analysis  
Diffraction patterns for the pure polymorphs were examined to identify regions of 
sufficient selectivity for either polymorph to be used for quantification studies.  A region with 
a well resolved diffraction peak, showing no overlap with the corresponding region for the 
alternative polymorph was desired.  The (101) peak of FII(6.403) at 15.8 º 2θ and the (014) 
peak of FIII(6.525) at 25.7 º 2θ were selected, and the change in intensity of these peaks as a 
function of FII(6.403) content is shown in Figure 3.  Accordingly, a simple univariate 
quantification method was attempted using the PXRD data
37
.  The PXRD patterns for 
calibration samples were analysed quantitatively by calculating the percentage of FII(6.403) 
using peak height intensities and area (equation 2, K=1), and relating this to the measured 
percentage weight composition.  The use of a response factor, K, to account for the difference 
in peak intensity, or area, observed for the (101) peak of FII and the (014) peak of FIII(6.525) 
in the diffraction pattern of pure FII(6.403) and FIII(6.525)  respectively, was also assessed. 
                (2) 
  (3) 
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The peak intensity and area for PXRD data were calculated with the X'Pert HighScore 
Plus software, which uses a mathematical function designed to identify the peaks present in 
the experimental pattern and their exact position and area.  The settings used for this 
procedure were a minimum peak significance of 1.00, minimum tip width of 0.01 º 2θ, 
maximum tip width of 1.00 º 2θ, and a peak base width of 2.00 º 2θ.  The univariate 
calibration correlations for FII calculated using peak intensity and peak area, without and 
with the response factor K, are presented in Figure 4.  While linear correlations were 
achieved, there was significant scatter around the lines resulting in poor correlation 
coefficients (Table 1).  A slightly higher linear correlation coefficient was achieved when a 
response factor K was used with the peak intensity data.  The calibration model(s) was tested 
by using a set of validation standards, and the results are presented in Table 2.  
The limit of detection (LOD) and limit of quantification (LOQ) for each correlation 
were calculated using equations 3 and 4, the standard deviation (STD) of three measurements 
of a sample with 95% FIII and the slope (m) of the calibration plot for the peak intensity and 
peak area:  
 LOD = (3 * STD)/ m   (4) 
          LOQ = (10 * STD)/ m    (5) 
 
Multivariate calibrations were performed on the 15.1–21.0 and 22.8–26.1 º 2θ range 
excluding the reflection around 21.3 and 21.7 º which exhibited extraordinary intensity 
variation with the concentration change of FII(6.403), as shown in Figure 3.  The PLS 
regression analysis used 45 PXRD scans from 15 calibration samples.  The best calibration 
model (requiring only 1 PLS factor) was achieved for the quantification of FII(6.403) in the 
binary mixtures when PXRD patterns of calibration samples were subjected to mean 
normalization.  The RMSEC, RMSECV and RMSEP values are presented in Table 1 and the 
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results show a significant improvement over the univariate analysis using peak intensity or 
peak area.  A good linear relationship was observed between the PLS predicted content of 
FII(6.403) against the measured content (Figure 5) with R
2
 of 0.997.  LOD and LOQ for the 
multivariate method were estimated using the same sample, and similar results were obtained 
(Table 2). 
3.3 Raman and NIR spectroscopic analysis 
Raman spectroscopy has distinct advantages in the analysis of solid materials because of 
the minimal sample preparation required and the non-contact, non-destructive nature of the 
measurement.  Different polymorphs of the same compound have different packing of 
molecules, and so the Raman spectra of the various polymorphs will be different due to subtle 
differences in molecular vibrations and rotations.  Recently, the polymorphic form (FII(6.403) 
or FIII(6.525)) of Piracetam produced from a cooling crystallization in ethanol was 
successfully monitored in situ by Raman spectroscopy 
38
.  Figure 6a shows the Raman 
spectra (from 250 cm
-1
 to 3310 cm
-1
) for the polymorphs FII and FIII of piracetam.  The band 
at 3140 cm
-1
 is due to symmetric stretching vibrations of NH2 while the 2750–2990 cm
-1 
bands can be assigned to the symmetric and anti symmetric stretching vibrations of the CH2 
groups.  The 1680 and 1650 cm
-1
 bands are ascribed to the C=O stretching vibrations in the 
ring and acetamide respectively.  The remaining Raman band assignments can be found in 
the literature. 
39
 It is noted that there are some differences in the Raman spectra of these two 
polymorphs.  For example, FII(6.403) has one characteristic amide peak at 1654 cm
-1
, while 
in FIII(6.525) the band is split into two at 1658 and 1648 cm
-1
.  There is also a peak specific 
to FIII(6.525) at 1410 cm
-1
 and band shifts in the region 1530–1370 cm-1.  Furthermore, band 
shifts are also observed between of 890–750 cm-1 which are related to changes in the bond 
lengths and angles made by atoms adjacent to the carbonyl group. 
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Partial least squares (PLS) regression analysis was carried out using the whole and 
several selected spectral regions of interest (RoI).  In addition, various pretreatment methods, 
including SNV, MSC, derivative and their combinations were used to reduce the effect of 
systematic variations, which are not related to the measured parameters.  The results 
suggested the spectral region from 1730–1370 cm-1 was the most suitable for quantification 
and therefore selected for the model.  The best PLS model was achieved for the quantification 
of FII(6.403) in these two binary mixtures when Raman data subjected to MSC and 2
nd
 
derivative treatment. MSC has been proved useful as it eliminated any light scattering from 
the powders and then subsequent use of the 2
nd
 derivative on these pre-processesd spectra 
gave more meaningful quantitative models with low RMSEC and RMSEP values of 0.94 % 
and 1.12 %, respectively.  
 
The plot of predicted vs. measured content of FII(6.403) is 
presented in Figure 7a and shows an R
2
 value of 0.999 with high linearity.   
NIR spectroscopy is also suitable for quantitative polymorph analysis and the method 
has been successfully applied to a wide variety of solid state characterizations
 12-15, 18, 21
.  The 
NIR spectra (Figure 6b and supplementary information) of these two polymorphs show some 
differences in the 5870–5600 and 4314–4080 cm-1 spectral regions.  For example, FII(6.403) 
has one peak at 5724 cm
-1
, while FIII(6.525) has two peaks at 5748 and 5708 cm
-1
.  In 
addition, FII(6.403) has one peak at 4364 cm
-1
, while FIII(6.525) has two peaks at 4380 and 
4358 cm
-1
.  These two spectral RoIs were combined and used to construct PLS model.  The 
optimal PLS model was generated after assessing the effects of several different 
pretreatments and combinations thereof.  This optimal model was obtained by using a 
combination of MSC and 2
nd
 derivative pretreatments, which gave a good linear relationship 
(R
2
 = 0.999) between the predicted and measured FII(6.403) content (Figure 7b). LOD and 
LOQ for the multivariate Raman and NIR based models were estimated from the mixtures 
containing 95% of FIII(6.525), and the results are listed in Table 2.  
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3.4 Comparison of the three techniques 
The above results clearly show that accurate quantification of FII(6.403) in binary 
mixtures with FIII is possible by either PXRD or spectroscopic analysis, but the 
spectroscopic methods outperform PXRD.  This is evident from the 95% confidence internals 
(Figure 5 and 7) where those of PXRD are much wider than for the Raman or NIR techniques.  
The RMSEC and RMSEP values for the Raman and NIR models are also significantly 
smaller than the PXRD model.  To further compare the accuracy of these three techniques, a 
set of validation samples containing different amounts of FII(6.403) were analyzed (Table 2).  
For example, determination of the sample 15% FII(6.403), Raman and NIR proved to be the 
most accurate, followed by PXRD with PLS analysis, while PXRD with peak intensity was 
the least accurate.  However as the FII(6.403) content increases the differences decrease, and, 
overall, NIR gives the most accurate predictions. 
It is well known that sample homogeneity is very important in the quantification of solid 
powder mixtures. In this study, all the samples were sieved using a 90 – 125 µm sieve 
fraction and samples were rotated during the PXRD acquisition. Nine measurements (from a 
3 x3 grid with 0.5 mm spacing) were performed on each sample for the Raman measurements 
to reduce potential errors which could arise from the small sampling size. To clarify this, the 
relative standard deviation (RSD) values of quantitation of the 95% FIII sample obtained 
from the average spectrum and from individual spectra were 6.22% and 58.81% respectively. 
The results clearly show that the increase in sampled volume using the 3 x 3 mapping reduces 
the errors associated with sub-sampling.  NIR spectra were collected from glass sample vials 
and the spectra were recorded from a sample area which was 15 mm in diameter. Each 
sample was measured in triplicate to reduce sampling errors arising from local inhomogeneity 
14
. 
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4 Conclusion 
Binary polymorphic mixtures of the nootropic drug Piracetam have been prepared and 
analyzed quantitatively by PXRD, Raman and NIR spectroscopy, coupled with univariate and 
multivariate analysis. The spectroscopic techniques gave superior correlation and proved 
accurate in quantifying a validation data set.  The FIII(6.525) polymorph of piracetam 
exhibits a degree of preferred orientation in XRD analysis, making quantification with this 
technique less accurate.   
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